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Abstract
Significant progress in computer hardware and software have enabled molecular
dynamics (MD) simulations to model complex biological phenomena such as protein
folding. However, enabling MD simulations to access biologically relevant timescales
(e.g., beyond milliseconds) still remains challenging. These limitations include (1)
quantifying which set of states have already been (sufficiently) sampled in an ensemble
of MD runs, and (2) identifying novel states from which simulations can be initiated to
sample rare events (e.g., sampling folding events). With the recent success of deep
learning and artificial intelligence techniques in analyzing large datasets, we posit that
these techniques can also be used to adaptively guide MD simulations to model such
complex biological phenomena. Leveraging our recently developed unsupervised deep
learning technique to cluster protein folding trajectories into partially folded
intermediates, we build an iterative workflow that enables our generative model to be
coupled with all-atom MD simulations to fold small protein systems on emerging high
performance computing platforms. We demonstrate our approach in folding Fs-peptide
and the ββα (BBA) fold, FSD-EY. Our adaptive workflow enables us to achieve an
overall root-mean squared deviation (RMSD) to the native state of 1.6 A˚ and 4.4 A˚
respectively for Fs-peptide and FSD-EY. We also highlight some emerging challenges in
the context of designing scalable workflows when data intensive deep learning
techniques are coupled to compute intensive MD simulations.
1 Introduction
Multiscale molecular simulations are widely used to model complex biological
phenomena, such as protein folding, protein-ligand (e.g., small molecule, ligand/ drug,
protein) interactions, and self-assembly [6, 14]. However, much of these phenomena
occur at timescales that are fundamentally challenging for molecular simulations to
access, even with advances in both hardware and software technologies [3]. Hence, there
is a need to develop scalable, adaptive simulation strategies that can enable sampling of
timescales relevant to these biological phenomena.
Many adaptive sampling techniques [4, 12,13,19,24,27] have been proposed. All
these techniques share some similar characteristics, including (a) the need for efficient
and automated approaches to identify a small number of relevant conformational
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coordinates (either through clustering and/or dimensionality reduction
techniques) [9, 23,25], and (b) the identification of the ‘next’ set of simulations to run
such that more trajectories are successful in attaining a specific end goal (e.g., protein
that is well folded, protein bound to its target ligand, etc.) [19,24].
These adaptive simulations present methodological and infrastructral challenges.
Ref. [13] provides important validation of the power of adaptive methods over traditional
“vanilla” molecular dynamics (MD) simulations or “ensemble” simulations. Ref. [1]
highlights challenges of such workflows on high-performance computing platforms.
We recently developed a deep learning based approach that uses convolutions and a
variational autoencoder (CVAE) to cluster simulations in an unsupervised manner [2].
We have shown that our CVAE can discover intermediate states from protein folding
pathways; further, the CVAE-learned latent dimensions cluster conformations into
biophysically relevant features such as number of native contacts, or root mean squared
deviation (RMSD) to the native state.
We posit that the CVAE learned latent features can be used to drive adaptive
sampling within MD simulations, where the next set of simulations to run are decided
based on a measure of ‘novelty’ of the simulation/ trajectory frame observed.
Integrating CVAE concurrently with large-scale ensemble simulations on
high-peformance computing platforms entails the aforementioned complexity of adaptive
workflows [1], while introducing additional infrastructural challenges. These arise from
the concurrent and adaptive execution of heterogeneous simulations and learning
workloads requiring sophisticated workload and performance balancing, inter alia.
In this paper, we implement a baseline version of our deep learning driven adaptive
sampling workflow with multiple concurrent instances of MD simulations and CVAEs.
Our contributions can be summarized as follows:
• We demonstrate that deep learning based approaches can be used to drive
adaptive MD simulations at scale. We demonstrate our approach in folding small
proteins, namely Fs-peptide and the β-β-α-fold (BBA) protein and show that it is
possible to fold them using deep learning driven adaptive sampling strategy.
• We highlight parallel computing challenges arising from the unique characteristics
of the worklfow, viz., training of deep learning algorithms can take almost as
much time as running simulations, necessitating novel developments to deal with
heterogeneous task placement, resource management and scheduling.
Taken together, our approach demonstrates the feasibility of coupling deep learning (DL)
and artificial intelligence (AI) workflows with conventional all-atom MD simulations.
2 Methods
2.1 Workflow description
Two key components of the workflow include the MD simulation module and the
deep-learning based CVAE module, which are described below.
Molecular dynamics (MD) simulations: The MD simulations are performed on
GPUs with OpenMM 7.3.0 [7]. Both the Fs-peptide and BBA systems were modeled
using the Amberff99SB-ildn force field [16] in implicit Onufriev-Bashford-Case GBSA
solvent model [20]. The non-bonded interactions are cut off at 10.0 A˚ and no periodic
boundary condition was applied. All the bonds to hydrogen are fixed to their
equilibrium value and simulations were run using a 2 fs time step. Langevin integrator
was used to maintain the system temperature at 300 K with a friction coefficient at 91
ps−1. The initial configuration was optimized using L-BFGS local energy minimizer
with tolerance of 10 kJ/mol and maximum of 100 iterations. The initial velocity is
assigned to each atom from a Boltzmann distribution at 300 K. We also added a new
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reporter to calculate the contact matrix of Cα atoms in the protein (using a distance
cut-off of 8 A˚ in hdf5 format using the MDAnalysis module [10,18] that could be used
as inputs to the deep learning module (described below). Each simulation run outputs a
frame every 50 ps.
Convolutional Variational Autoencoder (CVAE): Autoencoder is a deep
neural network architecture that can represent high dimensional data in a low
dimensional latent space while retaining the key information [5]. With its unique
hourglass shaped architecture, an autoencoder compresses input data into a latent space
with reduced dimension and reconstructs it to the original data. We use the CVAE to
cluster the conformations from our simulations in an unsupervised manner [2, 21].
Currently in our workflow, we use the number of latent dimensions as a hyperparameter
(varying between 3, 4, 5, 6) and use the CVAE that most accurately reconstructs the
input contact maps [2, 21]. CVAE was implemented using Keras/TensorFlow and
trained on a V100 GPU for 100 epochs.
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Figure 1. Deep generative model driven protein
folding simulation workflow.
Assembling our workflow:
As illustrated in Figure
1, our prototype workflow couples
the two components. In the first
stage, the objective is to initially
train the CVAE to determine
the optimal number of latent
dimensions required to faithfully
reconstruct the simulation data. We
commence our runs as an ensemble
of equilibrium MD simulations.
Ensemble MD simulations are
known to enable better sampling of
the conformational landscape, and also can be run in an embarrassingly parallel manner.
The simulation data is converted into a contact map representation (to overcome issues
with rotation/translation within the simulation box) and are streamed at regular
intervals into the CVAE module. The output from the first stage is an optimally
learned latent representation of the simulation data, which organizes the landscape into
clusters consisting of conformations with similar biophysical features (e.g., RMSD to the
native state). Note that this is an emergent property of the clustering and the RMSD to
the native state is not used as part of training data.
In the second stage, our objective is to identify the most viable/ promising next set
of starting states for propagating our MD simulations towards the folded state. We
switch the use of CVAE to infer from newly generated contact maps (from simulations)
and observe how they are clustered. Based on their similarity to the native state
(measured by the RMSD), a subset of these conformations are selected for propagating
additional MD runs. The workflow is continued until the protein is folded (i.e.,
conformations reach a user-defined RMSD value to the native state).
2.2 Implementation, Software and Compute Platform
We used the Celery software to implement the aforementioned workflow. Celery is an
asynchronous task scheduler with a flexible distributed system to process messages and
manage operations, which enables real-time task processing and scheduling. The tasks
can be executed and controlled by the Celery worker server asynchronously or
synchronously. Celery applications use callables to represent the modules that are part
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of the workflow. Once called, the task client adds to the task queue a message where its
unique name is referred so that the worker can locate the right function to execute. The
flexibility of Celery framework enables real-time interfacing to manage resource and
excise control over the task scheduling and execution. All tasks can be monitored and
controlled directly by the object functions. By calling the tasks at different stages of
their program, we simply build multi-task workflows, which supports a large volume of
concurrent tasks with real-time interfacing. The use of Celery framework allows us to
establish a baseline for estimating the compute requirements of our workflow. Our
workflow comprises of two callables, namely that of MD simulations, and the CVAE
used either in training or inference mode.
We tested our deep learning driven adaptive simulation framework on the NVIDIA
DGX-2 system at Oak Ridge National Laboratory (ORNL). The DGX-2 system
provides more than 2 petaflops of computational power from a single node that
leverages its 16 interconnected NVIDIA Tesla V100-SXM3-32GB GPUs. This enables
us to distribute the MD simulations and CVAE training onto 12 and 4 GPUs
respectively. All the components in the workflow are encapsulated within a Python
script that manages the various tasks through Celery. It first initializes the Celery
worker along with the selected broker, RabbitMQ. All 16 GPUs are then employed for
MD simulations to first generate 100,000 conformers as the initial training data for
CVAE. With 5 minute interval between iterations, the trained CVAEs continuously
compress Cα contact map of conformers from MD trajectories into data points in latent
space, which are subsequently evaluated with density-based spatial clustering of
applications with noise (DBSCAN) for identifying outlier conformations [8]. We used
DBSCAN for its relative simplicity and also to establish a baseline implementation of
our code. For Fs-peptide, outliers were collected all four trained CVAE models and only
CVAE with 6 dimensional latent space was applied for BBA outlier searching. In each
iteration, the MD runs are examined for outliers. Simulations that pass an initial
threshold of 20,000 frames (1 µs) for Fs-peptide and 10,000 (0.5 µs) for BBA, but do
not produce any outliers for the last 5000 frames (250 ns of simulation time) are purged.
With the available GPUs from such MD runs, new MD simulations are launched from
the the outliers to ensure appropriate resource management and usage.
3 Results
In previous work [2], we have shown that the CVAE can learn a latent space from the
Fs-peptide simulations such that the conformations from the simulations cluster into
distinct clusters consisting of folded and unfolded states. When parameters such as the
RMSD (to the native sztate) and the fraction of native contacts are used to annotate
the latent dimensions [11], we showed that these latent representations correspond to
reaction coordinates that describe how a protein may fold (beginning with the unfolded
state ensemble). Thus, we posit that we can propagate the simulations along these
low-dimensional representations and can drive simulations to sample folded states of the
protein in a relatively short number of iterations.
Figure 2 summarizes the results of our folding simulations of Fs-peptide. The
peptide consists of 21 residues – Ace-A5(AAARA)3A-NME – where Ace and NME
represent the N- and C-terminal end caps of the peptide respectively, and A represents
the amino acid Alanine, where as R represents the amino acid Arginine. It is often used
as a prototypical system for protein folding and adopts a fully helical structure as part
of its native state ensemble [17]. Previous simulations used implicit solvent simulations
using the GBSA-OBC potentials and the AMBER-FF99SB-ILDN force-field with an
aggregate simulation time of 14 µs at 300K [17]. We used the same settings for our MD
simulations and initiated our workflow. Summary statistics of the simulations are
provided in Table 1. A total of 90 iterations of the workflow was run to obtain a total
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Figure 2. CVAE-driven folding simulations of Fs-peptide.(A) Root mean squared
deviation (RMSD) with respect to the native/ folded state from the 31 trajectories
generated using our adaptive workflow for the Fs-peptide system. Only productive
simulations – i.e., simulations that achieve a RMSD cut-off of 4.5 A˚ or less are highlighted
for clarity. The rest of the simulations are shown in light gray. (B) A histogram of the
RMSD values in panel (A) depicting the RMSD cut-off for identifying folded, partially
folded, and unfolded ensembles from the data. The corresponding regions are also marked
in panel (A). (C) Using the RMSD to the native state as a measure of foldedness of the
system, we project the simulation data onto a three dimensional latent representation
learned by the CVAE. Note that the folded states (low RMSD values highlighted in
deeper shades of blue) are separated from the folding intermediate (shades of green
and yellow) and the unfolded states (darker shades of red).(D) A zoomed in projection
of the last 0.5 µs of simulations generated along with the original projections (shown
in pale gray, subsampled at every 100th snapshot). (E) highlights the same but just
showing the samples from the last 0.5 µs to highlight the differences between folded
and unfolded states. (F) shows representative snapshots from our simulations with
respect to the unfolded, partial folded, and native state ensembles. Note that the cartoon
representation shown in orange represents the native state (minimum RMSD of 1.6 A˚ to
reference structure) determined from our simulations.
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System Total no.
simulations
Total
simulation
time (µs)
(Shortest*,
Longest)
simulations
(µs)
Iterations Min.
RMSD (A˚)
Fs-peptide 31 54.198 1.01, 3.4 90 1.6
BBA (FSD-EY) 45 18.562 0.517,
0.873
100 4.44
Table 1. Summary statistics of simulations. *Only considering the simulations that
pass the initial threshold.
sampling of 54.198 µs. Note that the sampling time of the MD simulations is an
aggregate measure similar to the ones reported in previous studies.
We began by examining the RMSD with respect to the native state from all of our
simulations. As shown in Figure 2A, 13 of the total of 31 simulations are unproductive –
i.e., they do not sample the native state consisting of the fully formed α-helix. This is
not entirely surprising given that the starting state consists of a nearly linear peptide
with no residual secondary structures. Based on this observation, we posited that our
CVAE model can be used to identify partially folded states from the simulations. We
also examined the histogram of the RMSD values computed for each conformation with
respect to the native state ensemble (Figure 2B). Based on the histograms, we can
reasonably choose a threshold of 3.1A˚ or less to depict the folded state ensemble,
followed by 4.6 A˚ for partially folded states, and 8.3 A˚ for the unfolded states. Any
trajectory that shows RMSD values beyond 8.3 A˚ are only sampling the unfolded state
of the protein.
The projections of all the 31 simulations onto the learned CVAE is depicted in
Figure 2C. Collectively, z1-z3 provide a description of the Fs-peptide folding process.
Notably, much of the folded conformational states (highlighted in blue, indicating low
RMSD to the native state) are clustered together. Similarly, the unfolded conformations
(conformations colored in darker shades of red with higher RMSD to the native state
ensemble) are also clustered together. Taking this further, we examined if the similarity
in the conformations hold even with a smaller partition of the data (see Figures 2D and
E), namely the last 10% of the overall simulation data. This can be treated as a test set
from which new simulations are initiated. Notably, from these simulations we observe
the presence of roughly three arms in the projections (Figure 2E) consisting of: (1)
partially folded highlighted in shades of green/yellow, (2) unfolded state ensemble
highlighted in shades of red, and (3) a much smaller ensemble of folded states
(highlighted in blue).
For each of these states, we can also extract the structural characteristics with
respect to the folded state (Figure 2F). Many of the unfolded states do not consist of
any secondary structural features (top and bottom left panels). The partially folded
states consist of partial turns/ helical structures. The final folded state (with RMSD of
1.6 A˚) consists of most (if not all) helical turns in the protein.
3.1 Folding simulations of FSD-EY
The BBA protein namely, FSD-EY is a designed protein that adopts a β-β-α-fold in its
native state; however this protein tends to be dynamic in solution [15,22]. Similar to
other zinc-finger proteins, the structure of the protein can potentially vary, and
represents a challenging use-case for testing our workflow. As shown in Figure. 3, our
simulations do start with a completly unfolded state of the protein (average RMSD to
native state is about 12 A˚. Using an aggregated MD sampling time of 18 µs, we note
that we reach a RMSD value of 4.44 A˚.
Although we do not sample the native state of the protein consisting of the
β-β-α-fold, we are still able to sample regions of the landscape that consist of a defined
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Figure 3. CVAE-driven folding simulations of BBA-fold, FSD-EY. (A) RMSD plots
with respect to the native state of FSD-EY depicting the near-native state (blue),
partially folded states (green) and unfolded (red) trajectories similar to Figure 2. (B)
A histogram of the RSMD values to the native state. (C) The learned projections
from the CVAE for the trajecotries; similar to the Fs-peptide system, we can observe
the clustering of conformations based on their RMSD values to the native state. We
have used a RMSD cut-off of 10A˚ to highlight states closer to the native state. (D)
Although we could not fully fold the protein, we do observe the presence of a well-formed
hydrophobic core except for one residue (F25) at the C-terminal end of the protein.
hydrophobic core consisting of the highlighted residues in Figure 3D. Except for the
dynamic C-terminal end, where the hydrophobic interactions between F21 and F25 are
not entirely stable, the conformations that exhibit low RMSD values to the native state
depict the presence of this hydrophobic core. We expect that extending these
simulations further using the CVAE-driven protocol will enhance these interactions
allowing it to fold completely.
4 Discussion
As artificial intelligence (AI) and deep learning (DL) techniques become more pervasive
for analyzing scientific datasets, there is an emerging need for supporting AI/DL
coupled workflows to traditional HPC applications such as MD simulations. Our
approach provides a proof-of-concept for how we can guide MD simulations to sample
folded state ensemble of small proteins using DL techniques. The approach that we
chose was based on building a generative model for protein conformations and
identifying new starting conformations for additional MD sampling. Although the
generative model was only used to identify novel conformations for extending our MD
simulations, it nevertheless allowed us to guide the MD simulations towards sampling
folded conformations of the protein systems we considered.
Although DL approaches can take significantly longer time to train, we deliberately
chose a prototypic DL approach, namely CVAE, to train on our MD simulation data
(Table 2). As can be seen from the table, the computational cost of training and
inference times for the CVAE model is on par with the cost for running our MD
simulations. That is, within the time required to train our CVAE model, our MD
simulations progress only by about a nanosecond. Thus, starting up of new MD
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System DL training
(100 epochs;
minutes)
Time per
epoch (seconds)
Inference time
(ms/frame)
MD simulations
(ns per minute)
Fs-peptide 7 5 5.13 1.25
BBA 11 7 1.27 1.20
Table 2. Summary statistics of time taken by the individual components of our workflow:
(1) train and infer from the CVAE for each system, and (2) running the MD simulation.
simulations based on the guidance received from our CVAE model will not affect the
workflow’s overall performance. Further, our MD simulations were run using implicit
solvent models, which also significantly reduces their computational times. Further,
each contact map is no more than a couple of kilobytes of data and hence we did not
require the utilization of intrinsic capabilities of the NVIDIA DGX-2, including the
ability to potentially stream data across GPUs/ processors.
A primary motivation for this work was to use ML/DL based analysis to drive MD
simulations, and to calibrate results against non ML/DL driven approaches. In Ref. [9]
Fox et al introduced the concept of “Effective Performance” that is achieved by
combining learning with simulation and without changing the traditional system
characteristics. Our selection of physical systems, in particular the BBA peptide allows
to provide a coarse-grained estimate for the effective performance of CVAE based
adaptive sampling. Using Ref. [13] as reference data, we find that the effective
performance of CVAE based sampling is at least a factor of 20 greater than ”vanilla”
MSM based sampling approaches. Our estimate is based upon the convergence of
simulated BBA structures to its reference structures to within 4.5 A˚. Note that the
ExTASY based simulations in Ref. [13] are at least two orders of magnitude more
efficient that reference DE Shaw simulations. In future work, we will extend our effective
performance estimate to Villin head piece (VHP) and refine our estimates for BBA.
We expect that the concomitant increase in data sizes for larger MD simulations
would necessitate the use of streaming approaches. Similarly, as the time required to
train our DL models with data-/model- parallel approaches increases, it will require the
use of emerging memory hierarchy architectures to facilitate efficient data handling/
transfer across compute nodes that are dedicated for training and simulation. Further,
data intensive techniques such as reinforcement learning and/or active learning could
also have been used to guide our MD simulations.
The requirements of the ML/DL driven simulations outlined in this paper are
representative of ML/DL driven adaptive workflows — where the status of the
intermediate data analysis drive subsequent computations. Adaptive workflows pose
significant challenges [1] compared to workflows whose execution trajectory is
predetermined a priori. Further, the integration of diverse ML/DL approaches as the
intermediate analysis driving subsequent computations adds additional complexity,
which includes but is not limited to heterogeneous workload, load balancing and
resource management. Scalable execution and modern HPC platforms implies the need
for specialized middleware that support address these challenges. We are addressing
these aspects as part of ongoing work and future development built upon
RADICAL-Cybertools [1, 26].
The source code, associated datasets including the generated simulations and deep
learning models will be made available at the time of publication on
http://www.github.com.
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